Literature DB >> 1613260

The physical and functional behavior of capture antibodies adsorbed on polystyrene.

J E Butler1, L Ni, R Nessler, K S Joshi, M Suter, B Rosenberg, J Chang, W R Brown, L A Cantarero.   

Abstract

Six monoclonal and two polyclonal antibodies to fluorescein (FLU) were affinity purified and immobilized on Immulon 2 polystyrene as capture antibodies (CAbs): (a) by passive adsorption at pH 9.6, (b) via a streptavidin bridge to a biotinylated carrier molecule, and (c) via an antiglobulin which had been previously adsorbed passively to the polystyrene. Data show that less than 3.0% of the binding sites of monoclonal CAbs and approximately 5-10% of those of polyclonal CAbs were capable of capturing antigen (FLU4.2-BSA) after passive adsorption. Immobilization of CAbs via an antiglobulin or a streptavidin bridge, resulted in the preservation of antibody binding sites to greater than 70% for some monoclonals although immobilization via the streptavidin bridge resulted in the highest number of functional sites/well. The data presented are consistent with studies on other adsorbed proteins which demonstrate that passive adsorption on polystyrene results in the loss of protein function. Furthermore, these data show that generally less than half of the binding sites of antibodies available in solution are available after solid-phase immobilization even when non-adsorptive methods are employed. Some polyclonal anti-FLU also have lower average avidity following passive adsorption compared with CAbs immobilization via a streptavidin bridge. Immunochemical studies revealed that adsorbed polyclonal-CAbs performed like monoclonals when tested with multivalent antigens (FLU10-IgA) but in an expected heterogeneous manner in Scatchard plots when tested using univalent FLU-insulin. This observation implied cross-linking of immobilized CAbs by the multivalent antigen. Because only 5-10% of adsorbed polyclonal CAbs are active, the survivors must be non-randomly distributed in clusters to explain the cross-linking. This was confirmed by scanning electron microscopy which gave rise to the hypothesis that antibodies which retain activity after adsorption, are those present in clusters, i.e., the functional adsorbed CAb is an antibody cluster. Data presented in this report on the behavior of adsorbed CAbs, and reviewed from the work of others for various adsorbed proteins, indicate that the method of passive adsorption at pH 9.6, which is widely used in popular microtiter ELISAs, and which has in many ways revolutionized immunoassay, is a method of protein denaturation. Assayists that utilize passive adsorption of proteins on hydrophobic supports as part of their research need to be cognizant of this phenomenon, while inventors of immunoassay should develop alternative methods of immobilization which do not destroy 90% of the functional activity of solid-phase reactant.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1613260     DOI: 10.1016/0022-1759(92)90066-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  30 in total

1.  Biomimetic modification of metallic cardiovascular biomaterials: from function mimicking to endothelialization in vivo.

Authors:  Yajun Weng; Junying Chen; Qiufen Tu; Quanli Li; Manfred F Maitz; Nan Huang
Journal:  Interface Focus       Date:  2012-03-28       Impact factor: 3.906

2.  Analysis of glutathione S-transferase allergen cross-reactivity in a North American population: Relevance for molecular diagnosis.

Authors:  Geoffrey A Mueller; Lars C Pedersen; Jill Glesner; Lori L Edwards; Josefina Zakzuk; Robert E London; Luisa Karla Arruda; Martin D Chapman; Luis Caraballo; Anna Pomés
Journal:  J Allergy Clin Immunol       Date:  2015-04-28       Impact factor: 10.793

3.  A New Versatile Immobilization Tag Based on the Ultra High Affinity and Reversibility of the Calmodulin-Calmodulin Binding Peptide Interaction.

Authors:  Somnath Mukherjee; Marcin Ura; Robert J Hoey; Anthony A Kossiakoff
Journal:  J Mol Biol       Date:  2015-07-06       Impact factor: 5.469

4.  Accelerating phage-display library selection by reversible and site-specific biotinylation.

Authors:  Akiko Koide; John Wojcik; Ryan N Gilbreth; Annett Reichel; Jacob Piehler; Shohei Koide
Journal:  Protein Eng Des Sel       Date:  2009-09-08       Impact factor: 1.650

5.  Development of Improved Double-Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in Peripheral Blood Mononuclear Cells of Diabetic Patients and the Prefrontal Cortex of Multiple Sclerosis Patients.

Authors:  Dongyang Li; Christophe Morisseau; Cindy B McReynolds; Thomas Duflot; Jérémy Bellien; Rashed M Nagra; Ameer Y Taha; Bruce D Hammock
Journal:  Anal Chem       Date:  2020-04-27       Impact factor: 6.986

6.  Comparative study of antibody immobilization mediated by lipid and polymer fibers.

Authors:  Celine Cohn; Siu Ling Leung; Zhengbao Zha; Jessica Crosby; Weibing Teng; Xiaoyi Wu
Journal:  Colloids Surf B Biointerfaces       Date:  2015-06-19       Impact factor: 5.268

7.  Accessible Telemedicine Diagnostics with ELISA in a 3D Printed Pipette Tip.

Authors:  Mohamed Sharafeldin; Karteek Kadimisetty; Ketki R Bhalerao; Itti Bist; Abby Jones; Tianqi Chen; Norman H Lee; James F Rusling
Journal:  Anal Chem       Date:  2019-05-14       Impact factor: 6.986

8.  Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener's granulomatosis.

Authors:  Zhenru Feng; Ping Liu; Zhiyan Li; Baohuan Sui
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

9.  Heavy chain single-domain antibodies to detect native human soluble epoxide hydrolase.

Authors:  Yongliang Cui; Dongyang Li; Christophe Morisseau; Jie-Xian Dong; Jun Yang; Debin Wan; Martín A Rossotti; Shirley J Gee; Gualberto G González-Sapienza; Bruce D Hammock
Journal:  Anal Bioanal Chem       Date:  2015-07-31       Impact factor: 4.142

10.  Characterization for binding complex formation with site-directly immobilized antibodies enhancing detection capability of cardiac troponin I.

Authors:  Il-Hoon Cho; Sung-Min Seo; Jin-Woo Jeon; Se-Hwan Paek
Journal:  J Biomed Biotechnol       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.